Assessment of hematologic and metabolic indicators contributing to treatment outcomes of Covid-19 patients

Downloads

Download data is not yet available.

Supplementary Files

PDF (Tiếng Việt)     137    0

Abstract

Objectives: To evaluate hematological features and metabolic characteristics; and determine the contributing factors to the treatment outcome of COVID-19 patients. Methods: We conducted a cross-sectional descriptive study on 225 severe and critical COVID-19 patients treated at this COVID-19 Resuscitation Center from September 2021 to November 2021.

Results: There was an association between age and mortality caused by COVID-19, the age group over 60 has a 2.0 times higher risk of death than the group aged 60 and under. The hematological indices of leukocytes and platelets had statistically significant differences between the mortality group and the group of hospital discharge. The number of white blood cells in the mortality group was higher than the hospital discharge group, 17.5 (13.4 - 25.3) thousand/mm3 compared with 9.4 (6.4 - 13.6 thousand/mm3, p < 0.001). The rate of neutrophils in the mortality group was higher than in the discharge group, but the rate of lymphocytes was lower. The NLR index had a significant difference between the mortality group and the discharge group, 37.5 (20.1 - 52.8) compared with 11.8 (4.4 - 22.6), NLR could well mortality - predictdue to COVID-19 with AUC = 0.78. Using the 22.25 cut - off, the NLR had a sensitivity/specificity in predicting COVID-19 mortality of 74.2% and 74.5%, respectively. There was a statistically significant difference in platelet counts in the mortality and discharge groups, 166 (106 - 289) million/mm3 versus 236 (183 - 338) mm3.

https://doi.org/10.38103/jcmhch.2022.75.7

References

Coronavirus History: Origin and Evolution. 2021. https://www.webmd.com/lung/coronavirus-history

Bộ Y tế. Bộ Y tế - Công thông tin của Bộ Y tế về đại dịch COVID-19. https://covid19.gov.vn/

Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). StatPearl. Treasure Island (FL): StatPearls Publishing; 2021.

Gray WK, Navaratnam AV, Day J, Babu P, Mackinnon S, Adelaja I, et al. Variability in COVID-19 in-hospital mortality rates between national health service trusts and regions in England: A national observational study for the Getting It Right First Time Programme. EClinicalMedicine. 2021;35:100859.

Roth GA, Emmons-Bell S, Alger HM, Bradley SM, Das SR, de Lemos JA, et al. Trends in Patient Characteristics and COVID-19 In-Hospital Mortality in the United States During the COVID-19 Pandemic. JAMA Netw Open. 2021;4:e218828.

Bộ Y tế. Quyết định số 4689/QĐ-BYT ngày 06/10/2021: Hướng dẫn chẩn đoán và điều trị COVID-19 (cấp nhật lần thứ 7). Cục quản lý khám chữa bệnh. 2021. https://kcb.vn/quyet-dinh-so-4689-qd-byt-ngay-06-10-2021-huong-dan-chan-doan-va-dieu-tri-covid-19-cap-nhat-lan-thu-7.html

Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146:110-8.

Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern Med. 2020;180:1345-55.

CDC. Cases, Data, and Surveillance. Centers for Disease Control and Prevention. 2020.

Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A. The role of biomarkers in diagnosis of COVID-19 - A systematic review. Life Sci. 2020;254:117788.

Ulloque-Badaracco JR, Ivan Salas-Tallo W, Al-Kassab-Córdova A, Alarcón-Braga EA, Benites-Zapata VA, Maguiña JL, et al. Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 patients: A systematic review and meta-analysis. Int J Clin Pract. 2021;75:e14596.

Simadibrata DM, Calvin J, Wijaya AD, Ibrahim NAA. Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: A meta-analysis. Am J Emerg Med. 2021;42:60-9.

Yang A-P, Liu J-P, Tao Y-Q, Li H-M. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020;84:106504.

Sayah W, Berkane I, Guermache I, Sabri M, Lakhal FZ, Yasmine Rahali S, et al. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19. Cytokine. 2021;141:155428.

Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63:364-74.

Published 01-01-2022
Fulltext
Language
Issue No. 75 (2022)
Section Original article
DOI 10.38103/jcmhch.2022.75.7
Keywords COVID-19, bệnh nhân nặng và nguy kịch, NRL, bạch cầu, tiểu cầu, tử vong COVID-19, severe and critical patients, NRL, leukocytes, platelets, mortality

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2022 Journal of Clinical Medicine Hue Central Hospital

Trần Thừa Nguyên, Trần Quang Nhật, Nguyễn Thanh Xuân, Phạm Như Hiệp, Bùi Đức An Vinh, Huỳnh Lê Thái Bão, … Võ Quốc Huỳnh. (2022). Assessment of hematologic and metabolic indicators contributing to treatment outcomes of Covid-19 patients. Journal of Clinical Medicine Hue Central Hospital, (75), 49–57. https://doi.org/10.38103/jcmhch.2022.75.7